Literature DB >> 16042717

Epothilones and the next generation of phase III trials for prostate cancer.

Manish S Bhandari1, Maha Hussain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16042717     DOI： 10.1111/j.1464-410X.2005.05618.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  4 in total

1.  Castration-resistant prostate cancer: new science and therapeutic prospects.

Authors:  Joaquim Bellmunt; William K Oh
Journal:  Ther Adv Med Oncol       Date:  2010-05       Impact factor: 8.168

2.  Synthesis and antiproliferative activity of novel 2-aryl-4-benzoyl-imidazole derivatives targeting tubulin polymerization.

Authors:  Jianjun Chen; Chien-Ming Li; Jin Wang; Sunjoo Ahn; Zhao Wang; Yan Lu; James T Dalton; Duane D Miller; Wei Li
Journal:  Bioorg Med Chem       Date:  2011-07-01       Impact factor: 3.641

3.  Chemotherapy in Androgen-Independent Prostate Cancer (AIPC): What's next after taxane progression?

Authors:  Jeanny B Aragon-Ching; William L Dahut
Journal:  Cancer Ther       Date:  2007

Review 4.  Epothilones: tubulin polymerization as a novel target for prostate cancer therapy.

Authors:  James J Lee; W Kevin Kelly
Journal:  Nat Clin Pract Oncol       Date:  2008-12-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.